General Announcement::Notification to Bondholders regarding the initial Conversion Price

Issuer & Securities

Announcement Title: General Announcement
Date &Time of Broadcast: 05-Dec-2017 18:32:54
Status: New
Announcement Sub Title: Notification to Bondholders regarding the initial Conversion Price
Announcement Reference: SG171205OTHRMY2L
Submitted By (Co./ Ind. Name): Glenmark Pharmaceuticals Limited
Designation: Company Secretary & Compliance Officer
Effective Date and Time of the event: 05/12/2017 15:00:00
Description (Please provide a detailed description of the event in the box below): Re: Notification to Bondholders regarding the initial Conversion Price.

Reference is hereby made to the Trust Deed dated 28 June 2016 (the Trust Deed ) between Glenmark Pharmaceuticals Limited (the Company ) and The Bank of New York Mellon, London Branch, relating to the 2.00 per cent. Resettable Onward Starting Equity-linked Securities due 2022 convertible into ordinary shares of the Company (the Bonds ). Notice is hereby given to Bondholders that, on 30 November 2017, the Company set the initial Conversion Price (i.e. the price at which ordinary shares of the Company will be issued upon conversion of the Bonds (subject to any further adjustments in accordance with the Conditions)) at Rs. 861.84, as determined in accordance with Condition 6.1.3 of the Trust Deed. Capitalized terms used in this notice and not otherwise defined shall have the respective meanings set out in the Trust Deed.

Total size =46K